2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Directly Observed Therapy: new trials by email Literature Review of Directly Observed Therapy trials Research Report on Directly Observed Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C] Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a - Hepatitis C, Chronic | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 150 | 2018-02-02 | 2021-05-18 |
| Directly Observed Therapy in High Risk Populations in Newark, NJ Invirase, Norvir - Directly Observed Therapy, HIV Infections | Phase 3 | Completed | Saint Michael's Medical Center | 30 | 2004-04-01 | 2006-02-28 |
HIV Infections (1) · Hepatitis C, Chronic (1)
Behavior (2) · Blood-Borne Infections (2) · Communicable Diseases (2) · Health Behavior (2) · Infections (2) · Medication Adherence (2) · Patient Acceptance of Health Care (2) · Patient Compliance (2) · RNA Virus Infections (2) · Treatment Adherence and Compliance (2) · Virus Diseases (2) · Chronic Disease (1) · Digestive System Diseases (1) · Disease Attributes (1) · Flaviviridae Infections (1)
Ritonavir (1) · Saquinavir (1) · Sofosbuvir (1) · daclatasvir (1) · peginterferon alfa-2a (1)
Johns Hopkins Bloomberg School of Public Health (1) · Saint Michael's Medical Center (1)
India (1) · United States (1)
Jihad Slim, MD (1) · Shruti Mehta, PhD, MPH (1)
R01DA026727 (1)